Trial intelligence / Profile preview

LIBRA: Short Versus Long-term Levetiracetam in Brain Tumors

NCT06442748Phase 3Recruiting

Sponsor
Tata Memorial Centre
Start
Jul 2024
Primary completion
Jun 2031
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of levetiracetam in epilepsy, sponsored by Tata Memorial Centre. Started Jul 2024; status: recruiting.

02

Drugs

levetiracetam
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT06442748.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06442748.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call